Global Novel Drug Delivery Systems Competitive Landscape Professional Research Report 2024
Description
Global Novel Drug Delivery Systems Competitive Landscape Professional Research Report 2024
Research Summary
Novel drug delivery systems (NDDS) refer to innovative techniques or approaches used to deliver pharmaceutical substances to the body in a targeted and controlled manner. These systems aim to improve the therapeutic efficacy, safety, and convenience of drug administration by overcoming the limitations associated with conventional drug delivery methods. NDDS can include various technologies and formulations such as nanoparticles, liposomes, microparticles, implants, patches, inhalers, and transdermal systems. They often employ specialized carriers or vehicles to encapsulate and protect drugs, enabling controlled release, site-specific targeting, and enhanced drug stability. These advanced delivery systems offer advantages like improved drug bioavailability, reduced side effects, prolonged drug action, and enhanced patient compliance. NDDS play a crucial role in personalized medicine, precision therapy, and the development of therapeutic approaches for complex diseases. By exploring innovative ways to deliver drugs, NDDS contributes to advancements in therapeutic outcomes and patient care.
According to DIResearch's in-depth investigation and research, the global Novel Drug Delivery Systems market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch & Lomb, Johnson & Johnson, Samyang Biopharmaceuticals, TOLMAR, Astellas, AbbVie, AMAG Pharmaceuticals, AstraZeneca, Dr Reddy, Aspen, Acrotech Biopharma, TWi Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Novel Drug Delivery Systems. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Novel Drug Delivery Systems market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Novel Drug Delivery Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Novel Drug Delivery Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Novel Drug Delivery Systems Include:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch & Lomb
Johnson & Johnson
Samyang Biopharmaceuticals
TOLMAR
Astellas
AbbVie
AMAG Pharmaceuticals
AstraZeneca
Dr Reddy
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Novel Drug Delivery Systems Product Segment Include:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Novel Drug Delivery Systems Product Application Include:
Hospitals & Clinic
Cancer Treatment Centers
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Novel Drug Delivery Systems Industry PESTEL Analysis
Chapter 3: Global Novel Drug Delivery Systems Industry Porter’s Five Forces Analysis
Chapter 4: Global Novel Drug Delivery Systems Major Regional Market Size and Forecast Analysis
Chapter 5: Global Novel Drug Delivery Systems Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Novel Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Novel Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Novel Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Novel Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Novel Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Novel Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Novel Drug Delivery Systems Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Novel Drug Delivery Systems Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Novel Drug Delivery Systems Product by Type
- 1.2.1 Global Novel Drug Delivery Systems Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Liposomes
- 1.2.3 PEGylated Proteins & Polypeptides
- 1.2.4 Polymer Nanoparticle
- 1.2.5 Protein–drug Conjugates
- 1.2.6 Others
- 1.3 Novel Drug Delivery Systems Product by Application
- 1.3.1 Global Novel Drug Delivery Systems Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Hospitals & Clinic
- 1.3.3 Cancer Treatment Centers
- 1.3.4 Others
- 1.4 Global Novel Drug Delivery Systems Market Revenue Analysis (2019-2030)
- 1.5 Novel Drug Delivery Systems Market Development Status and Trends
- 1.5.1 Novel Drug Delivery Systems Industry Development Status Analysis
- 1.5.2 Novel Drug Delivery Systems Industry Development Trends Analysis
- 2 Novel Drug Delivery Systems Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Novel Drug Delivery Systems Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Novel Drug Delivery Systems Market Analysis by Regions
- 4.1 Novel Drug Delivery Systems Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Novel Drug Delivery Systems Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Novel Drug Delivery Systems Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Novel Drug Delivery Systems Revenue Forecast by Region (2025-2030)
- 5 Global Novel Drug Delivery Systems Market Size by Type and Application
- 5.1 Global Novel Drug Delivery Systems Market Size by Type
- 5.2 Global Novel Drug Delivery Systems Market Size by Application
- 6 North America
- 6.1 North America Novel Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Novel Drug Delivery Systems Market Size by Type
- 6.4 North America Novel Drug Delivery Systems Market Size by Application
- 6.5 North America Novel Drug Delivery Systems Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Novel Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Novel Drug Delivery Systems Market Size by Type
- 7.4 Europe Novel Drug Delivery Systems Market Size by Application
- 7.5 Europe Novel Drug Delivery Systems Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Novel Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Novel Drug Delivery Systems Market Size by Type
- 8.4 China Novel Drug Delivery Systems Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Novel Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Novel Drug Delivery Systems Market Size by Type
- 9.4 APAC (excl. China) Novel Drug Delivery Systems Market Size by Application
- 9.5 APAC (excl. China) Novel Drug Delivery Systems Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Novel Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Novel Drug Delivery Systems Market Size by Type
- 10.4 Latin America Novel Drug Delivery Systems Market Size by Application
- 10.5 Latin America Novel Drug Delivery Systems Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Novel Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Type
- 11.4 Middle East & Africa Novel Drug Delivery Systems Market Size by Application
- 11.5 Middle East & Africa Novel Drug Delivery Systems Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Novel Drug Delivery Systems Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Novel Drug Delivery Systems Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Novel Drug Delivery Systems Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Amgen
- 13.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Amgen Novel Drug Delivery Systems Product Portfolio
- 13.1.3 Amgen Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Teva
- 13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Teva Novel Drug Delivery Systems Product Portfolio
- 13.2.3 Teva Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Roche
- 13.3.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Roche Novel Drug Delivery Systems Product Portfolio
- 13.3.3 Roche Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 UCB (Union Chimique Belge)
- 13.4.1 UCB (Union Chimique Belge) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Portfolio
- 13.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Celgene
- 13.5.1 Celgene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Celgene Novel Drug Delivery Systems Product Portfolio
- 13.5.3 Celgene Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Merck
- 13.6.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Merck Novel Drug Delivery Systems Product Portfolio
- 13.6.3 Merck Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Gilead Sciences
- 13.7.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Gilead Sciences Novel Drug Delivery Systems Product Portfolio
- 13.7.3 Gilead Sciences Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Sanofi
- 13.8.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Sanofi Novel Drug Delivery Systems Product Portfolio
- 13.8.3 Sanofi Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Pfizer
- 13.9.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Pfizer Novel Drug Delivery Systems Product Portfolio
- 13.9.3 Pfizer Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 Takeda
- 13.10.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Takeda Novel Drug Delivery Systems Product Portfolio
- 13.10.3 Takeda Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Bausch & Lomb
- 13.11.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Bausch & Lomb Novel Drug Delivery Systems Product Portfolio
- 13.11.3 Bausch & Lomb Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Johnson & Johnson
- 13.12.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Johnson & Johnson Novel Drug Delivery Systems Product Portfolio
- 13.12.3 Johnson & Johnson Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.13 Samyang Biopharmaceuticals
- 13.13.1 Samyang Biopharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 13.13.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.14 TOLMAR
- 13.14.1 TOLMAR Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 TOLMAR Novel Drug Delivery Systems Product Portfolio
- 13.14.3 TOLMAR Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.15 Astellas
- 13.15.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Astellas Novel Drug Delivery Systems Product Portfolio
- 13.15.3 Astellas Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.16 AbbVie
- 13.16.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 AbbVie Novel Drug Delivery Systems Product Portfolio
- 13.16.3 AbbVie Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.17 AMAG Pharmaceuticals
- 13.17.1 AMAG Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 13.17.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.18 AstraZeneca
- 13.18.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 AstraZeneca Novel Drug Delivery Systems Product Portfolio
- 13.18.3 AstraZeneca Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.19 Dr Reddy
- 13.19.1 Dr Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Dr Reddy Novel Drug Delivery Systems Product Portfolio
- 13.19.3 Dr Reddy Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.20 Aspen
- 13.20.1 Aspen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 Aspen Novel Drug Delivery Systems Product Portfolio
- 13.20.3 Aspen Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.21 Acrotech Biopharma
- 13.21.1 Acrotech Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.21.2 Acrotech Biopharma Novel Drug Delivery Systems Product Portfolio
- 13.21.3 Acrotech Biopharma Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.22 TWi Pharmaceuticals
- 13.22.1 TWi Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.22.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 13.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Novel Drug Delivery Systems Industry Chain Analysis
- 14.2 Novel Drug Delivery Systems Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Novel Drug Delivery Systems Typical Downstream Customers
- 14.4 Novel Drug Delivery Systems Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
